Press Releases

Webcast
Q4 2017 Geron Earnings Conference Call
Mar 19, 2018 at 8:30 AM EDT
Webcast Presentation

Q4 2017 Geron Earnings Conference Call
Mar 19, 2018 at 8:30 AM EDT
Webcast
Geron at 17th Annual Needham Healthcare Conference
Mar 27, 2018 at 4:00 PM EDT
Webcast Presentation

Geron at 17th Annual Needham Healthcare Conference
Mar 27, 2018 at 4:00 PM EDT
Date Title and Summary  
Toggle Summary Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2017 Financial Results
MENLO PARK, Calif. , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2017 , on Friday, March 16, 2018 , after the market close. Geron’s management will also host a conference call for analysts
Toggle Summary Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting
Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes (MDS) Presented Analyst and Investor Meeting and Webcast at 8:30 a.m. ET on December 19, 2017 MENLO PARK, Calif. , Dec. 12, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced four presentations related
Toggle Summary Geron to Host Analyst and Investor Meeting and Webcast on December 19, 2017
Management to be joined by external guest speaker to review imetelstat data from IMerge to be presented at the 59th American Society of Hematology Annual Meeting and Exposition MENLO PARK, Calif. , Dec. 06, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that the company’s
Toggle Summary Geron Announces First Patient Dosed in Expanded Part 1 of IMerge Clinical Trial in Myelodysplastic Syndromes
MENLO PARK, Calif. , Nov. 20, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that the first patient has been dosed in the expanded Part 1 of IMerge, the ongoing Phase 2/3 clinical trial of imetelstat in transfusion dependent patients with Low or Intermediate-1 risk
Toggle Summary Geron Announces November Investor Conference Presentation Webcasts
MENLO PARK, Calif. , Nov. 07, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett , M.D., President and Chief Executive Officer, is scheduled to present at the following investor conferences: Stifel 2017 Healthcare Conference in New York at 4:15 p.m.
Toggle Summary Geron Corporation Reports Third Quarter 2017 Financial Results
MENLO PARK, Calif. , Nov. 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and nine months ended September 30, 2017 . For the third quarter of 2017, the company reported a net loss of $6.9 million , or $0.04 per share, compared to $3.6
Toggle Summary Geron Announces Presentations at American Society of Hematology Annual Meeting
Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes to be Presented MENLO PARK, Calif. , Nov. 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that four abstracts related to the telomerase inhibitor imetelstat have been accepted for presentation
Toggle Summary Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndromes
Expanded Part 1 of IMerge is Open for Patient Enrollment MENLO PARK, Calif. , Oct. 31, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that the United States Food and Drug Administration ( FDA ) has granted Fast Track designation to imetelstat for the potential treatment of
Toggle Summary Geron Announces Conference Call to Discuss Third Quarter 2017 Financial Results
MENLO PARK, Calif. , Oct. 25, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the third quarter ended September 30, 2017 , on Wednesday, November 1, 2017 , after the market close. Geron’s management will also host a conference call for analysts and
Toggle Summary Geron to Present at the Cantor Fitzgerald Healthcare Conference
MENLO PARK, Calif. , Sept. 19, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett , M.D., President and Chief Executive Officer, is scheduled to present at the Cantor Fitzgerald Global Healthcare Conference in New York at 1:40 p.m.